-
About Michelson Diagnostics
Michelson Diagnostics. Microscopy Systems. Michelson Diagnostics Ltd (MDL) is a healthcare company providing a live view of cancerous tissue. The company was formed in March 2006 to develop a hand-held cancer scanner based on an imaging technology called optical coherence tomography (OCT). The patented device will give clinicians and researchers a live view of sub-surface tissue structures at near-cellular resolution - high enough to see the emergence and growth of cancer. It shows tissue as deep as 2 mm and offers much higher image resolution than ultrasound or MRI. The non-invasive cancer scan reduces the need for painful and costly biopsies and provides patients and doctors with immediate results. Whole organs can be systematically scanned for abnormalities.
-
Quotes about Michelson Diagnostics
-
I found the MedTech Tour Summit extremely useful: the high standard of presenting companies at different stages of their business development provided insights into how I need to position Michelson Diagnostics for an investment. I also made contact with several interested investors and advisors, and discussions are progressing.
In Michelson Diagnostics is Singled Out for Growth -
Michelson Diagnostics has applied their outstanding technology to forward thinking products and I am extremely pleased to be representing the company in the US.
In Michelson Diagnostics Opens US Offices And Appoints US Business Development Manager -
This is a remarkable milestone for Michelson Diagnostics, as it shows, through a statistically significant sample, that multi-beam OCT technology has the potential to play an important role in the early diagnosis of cancer.
In Michelson Diagnostics Reports First Quantitative Results on Cancer Diagnosis Using Multi-beam OCT imaging
-